Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-19-000278
Filing Date
2019-02-14
Accepted
2019-02-14 16:30:49
Documents
1
Group Members
ABRAMS CAPITAL MANAGEMENT, LLCABRAMS CAPITAL PARTNERS II L.P.ABRAMS CAPITAL, LLCDAVID ABRAMS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 abrams13ga.htm SC 13G/A 100361
  Complete submission text file 0000929638-19-000278.txt   102078
Mailing Address 222 BERKELEY STREET, 21ST FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 21ST FLOOR BOSTON MA 02116 617-646-6100
ABRAMS CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001358706 (see all company filings)

IRS No.: 204043368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Subject) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88058 | Film No.: 19607080
SIC: 2834 Pharmaceutical Preparations